Country specific reports on the topic are available for purchase. Please contact us.
GlobalData, the industry analysis specialist, has released its new report, "Healthcare, Regulatory and Reimbursement Landscape - Vietnam". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape of Vietnam. It identifies the key trends in the healthcare market of Vietnam and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of the country. Most importantly, the report provides valuable insights on the trends and segmentation of the pharmaceutical market. This report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData's team of industry experts.
The population of Vietnam was approximately 86.5 million in 2010, making it the 13th most populated country in the world. This increase in the population is primarily due to a high birth rate and an increase in life expectancy. An increasing disease burden is a matter of concern for policy planners in Vietnam. The pharmaceutical market in the country was $1.9 billion in 2010 and is expected to reach approximately $5.8 billion by 2020 at a projected CAGR of 12%.
The positive trend in the healthcare market of Vietnam can be primarily attributed to -
The report provides information on the healthcare, regulatory and reimbursement landscape of Vietnam. The scope of the report includes -
This report comprehensively covers the pharmaceutical market of Vietnam. It will enhance your decision making capability and will allow you to -
Browse more Drug Regulation Market Research Reports